KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Gains from Investment Securities (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Gains from Investment Securities for 17 consecutive years, with $5.0 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities changed 0.0% to $5.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Dec 2025, down 7.69% year-over-year, with the annual reading at $24.0 million for FY2025, 7.69% down from the prior year.
  • Gains from Investment Securities hit $5.0 million in Q3 2025 for Bausch Health Companies, up from $3.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $34.0 million in Q3 2022 to a low of -$29.0 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $8.3 million across 5 years, with a median of $6.0 million in 2021.
  • Biggest YoY gain for Gains from Investment Securities was 277.78% in 2022; the steepest drop was 583.33% in 2022.
  • Year by year, Gains from Investment Securities stood at $19.0 million in 2021, then tumbled by 94.74% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then surged by 200.0% to $3.0 million in 2024, then soared by 66.67% to $5.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for BHC at $5.0 million in Q3 2025, $3.0 million in Q2 2025, and $16.0 million in Q1 2025.